Cargando…
miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells
Expression of miR-342 has been strongly correlated with estrogen receptor (ER) status in breast cancer, where it is highest in ER-positive and lowest in triple-negative tumors. We investigated the effects of miR-342 transfection in the triple-negative breast cancer cell lines MDA-MB-231 and HCC1937,...
Autores principales: | Crippa, Elisabetta, Folini, Marco, Pennati, Marzia, Zaffaroni, Nadia, Pierotti, Marco A., Gariboldi, Manuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951312/ https://www.ncbi.nlm.nih.gov/pubmed/26919240 http://dx.doi.org/10.18632/oncotarget.7617 |
Ejemplares similares
-
miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
por: Crippa, Elisabetta, et al.
Publicado: (2014) -
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
por: Tassone, P, et al.
Publicado: (2003) -
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Bajrami, Ilirjana, et al.
Publicado: (2021) -
Defeat mutant KRAS with synthetic lethality
por: Pang, Xiufeng, et al.
Publicado: (2016) -
Reduced repair of 8-hydroxyguanine in the human breast cancer cell line, HCC1937
por: Nyaga, Simon G, et al.
Publicado: (2006)